Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rayomand Press

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 4, 2023
Neurodegenerative biomarkers outperform neuroinflammatory biomarkers in amyotrophic lateral sclerosisUlf Kläppe, Stefan Sennfält, Anikó Lovik, et al.
European Journal of Human Genetics : EJHG|January 26, 2012
Homozygous SMN2 deletion is a protective factor in the Swedish ALS populationPhilippe Corcia, Caroline Ingre, Helene Blasco, et al.
Neurobiology of Aging|November 13, 2012
A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohortsCaroline Ingre, John E Landers, Naji Rizik, et al.
Brain Communications|May 19, 2025
Plasma troponin T reflects lower motor neuron involvement on electromyography in amyotrophic lateral sclerosisSanharib Chamoun, Sofia Imrell, Zane Upate, et al.
Muscle & Nerve|September 25, 2018
Screening for Fabry disease and Hereditary ATTR amyloidosis in idiopathic small-fiber and mixed neuropathyKristin Samuelsson, Ana Radovic, Rayomand Press, et al.
Nature Communications|November 8, 2022
T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progressionSolmaz Yazdani, Christina Seitz, Can Cui, et al.
Frontiers in Neurology|June 5, 2023
Genome sequencing with comprehensive variant calling identifies structural variants and repeat expansions in a large fraction of individuals with ataxia and/or neuromuscular disordersMarlene Ek, Daniel Nilsson, Martin Engvall, et al.
Brain : a Journal of Neurology|June 22, 2014
Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomesAlexander Carvajal-González, M Isabel Leite, Patrick Waters, et al.
JAMA Neurology|September 19, 2022
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis: The RINOMAX Randomized Clinical TrialFredrik Piehl, Ann Eriksson-Dufva, Anna Budzianowska, et al.
European Journal of Neurology|November 6, 2025
Rituximab in New-Onset Generalized Myasthenia Gravis: Long-Term Follow-Up of the RINOMAX Clinical TrialJing Wu, Ann Eriksson-Dufva, Anna Budzianowska, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 4, 2023
Neurodegenerative biomarkers outperform neuroinflammatory biomarkers in amyotrophic lateral sclerosisUlf Kläppe, Stefan Sennfält, Anikó Lovik, et al.
European Journal of Human Genetics : EJHG|January 26, 2012
Homozygous SMN2 deletion is a protective factor in the Swedish ALS populationPhilippe Corcia, Caroline Ingre, Helene Blasco, et al.
Neurobiology of Aging|November 13, 2012
A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohortsCaroline Ingre, John E Landers, Naji Rizik, et al.
Brain Communications|May 19, 2025
Plasma troponin T reflects lower motor neuron involvement on electromyography in amyotrophic lateral sclerosisSanharib Chamoun, Sofia Imrell, Zane Upate, et al.
Muscle & Nerve|September 25, 2018
Screening for Fabry disease and Hereditary ATTR amyloidosis in idiopathic small-fiber and mixed neuropathyKristin Samuelsson, Ana Radovic, Rayomand Press, et al.
Nature Communications|November 8, 2022
T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progressionSolmaz Yazdani, Christina Seitz, Can Cui, et al.
Frontiers in Neurology|June 5, 2023
Genome sequencing with comprehensive variant calling identifies structural variants and repeat expansions in a large fraction of individuals with ataxia and/or neuromuscular disordersMarlene Ek, Daniel Nilsson, Martin Engvall, et al.
Brain : a Journal of Neurology|June 22, 2014
Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomesAlexander Carvajal-González, M Isabel Leite, Patrick Waters, et al.
JAMA Neurology|September 19, 2022
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis: The RINOMAX Randomized Clinical TrialFredrik Piehl, Ann Eriksson-Dufva, Anna Budzianowska, et al.
European Journal of Neurology|November 6, 2025
Rituximab in New-Onset Generalized Myasthenia Gravis: Long-Term Follow-Up of the RINOMAX Clinical TrialJing Wu, Ann Eriksson-Dufva, Anna Budzianowska, et al.
Pageof 6